IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q4 2023 Holdings

Filed 2024-02-13 | 13 holdings | $394.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Karuna Therapeutics IncCOM48576A100$252.3M797,00864.0%
Vaxcyte Inc(PCVX)COM92243G108$49.8M793,03612.6%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$21.2M1,888,7885.4%
Inozyme Pharma IncCOM45790W108$19.1M4,494,8514.9%
Fusion Pharmaceuticals IncCOM36118A100$15.0M1,560,9823.8%
Gracell Biotechnologies IncSPONSORED ADS38406L103$13.8M1,375,0003.5%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$6.2M1,910,0091.6%
Rallybio CorpCOM75120L100$5.7M2,404,6441.5%
Exscientia PLCADS30223G102$4.9M770,5001.3%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$2.1M1,891,4670.5%
Vigil Neuroscience Inc(VIGL)COM92673K108$1.9M560,5950.5%
IO Biotech Inc(IOBT)COM449778109$1.6M864,1970.4%
Aligos Therapeutics IncCOM01626L105$493.5K743,2150.1%